Compare TTK HEALTHCARE with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE FRESENIUS KABI ONCO. TTK HEALTHCARE/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 12.5 22.1 56.3% View Chart
P/BV x 1.8 3.1 58.1% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 TTK HEALTHCARE   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
FRESENIUS KABI ONCO.
Mar-13
TTK HEALTHCARE/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs1,215176 690.3%   
Low Rs61079 777.2%   
Sales per share (Unadj.) Rs444.437.7 1,179.1%  
Earnings per share (Unadj.) Rs17.25.1 338.6%  
Cash flow per share (Unadj.) Rs27.66.7 411.0%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.942.5 418.2%  
Shares outstanding (eoy) m14.13158.23 8.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.13.4 60.8%   
Avg P/E ratio x52.925.0 211.8%  
P/CF ratio (eoy) x33.018.9 174.5%  
Price / Book Value ratio x5.13.0 171.5%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,89420,135 64.0%   
No. of employees `0002.31.2 200.7%   
Total wages/salary Rs m1,307703 185.9%   
Avg. sales/employee Rs Th2,715.75,176.2 52.5%   
Avg. wages/employee Rs Th565.3610.4 92.6%   
Avg. net profit/employee Rs Th105.4699.6 15.1%   
INCOME DATA
Net Sales Rs m6,2795,963 105.3%  
Other income Rs m7818 430.6%   
Total revenues Rs m6,3565,981 106.3%   
Gross profit Rs m4961,430 34.7%  
Depreciation Rs m147258 56.9%   
Interest Rs m34-26 -130.0%   
Profit before tax Rs m3931,216 32.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m149342 43.5%   
Profit after tax Rs m244806 30.2%  
Gross profit margin %7.924.0 32.9%  
Effective tax rate %37.928.1 134.8%   
Net profit margin %3.913.5 28.7%  
BALANCE SHEET DATA
Current assets Rs m2,7175,102 53.3%   
Current liabilities Rs m1,5712,385 65.9%   
Net working cap to sales %18.345.6 40.1%  
Current ratio x1.72.1 80.9%  
Inventory Days Days32150 21.4%  
Debtors Days Days47113 41.2%  
Net fixed assets Rs m9915,148 19.2%   
Share capital Rs m141158 89.3%   
"Free" reserves Rs m2,3736,556 36.2%   
Net worth Rs m2,5146,732 37.3%   
Long term debt Rs m3952 0.4%   
Total assets Rs m4,15810,388 40.0%  
Interest coverage x12.6-45.8 -27.6%   
Debt to equity ratio x00.1 1.0%  
Sales to assets ratio x1.50.6 263.1%   
Return on assets %6.77.5 88.9%  
Return on equity %9.712.0 81.0%  
Return on capital %16.914.6 116.0%  
Exports to sales %3.674.5 4.8%   
Imports to sales %0.524.8 2.0%   
Exports (fob) Rs m2254,441 5.1%   
Imports (cif) Rs m311,477 2.1%   
Fx inflow Rs m2255,298 4.3%   
Fx outflow Rs m711,772 4.0%   
Net fx Rs m1543,525 4.4%   
CASH FLOW
From Operations Rs m1731,274 13.6%  
From Investments Rs m97-1,204 -8.0%  
From Financial Activity Rs m-307-196 156.7%  
Net Cashflow Rs m-38-126 29.8%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 3.7 0.3 1,233.3%  
FIIs % 5.2 9.6 54.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 9.1 283.5%  
Shareholders   12,723 42,599 29.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PROCTER & GAMBLE HEALTH  STERLING BIOTECH  TORRENT PHARMA  VENUS REMEDIES  CIPLA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Lower, Dow Futures Down by 128 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 328 points, down 0.7% at 48,833 levels.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 12, 2021 03:36 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS